Filter News

Shamrock Structures Release: Shamrock Oncology To Harness Big Data To Drive Drug Discovery In Personalized Cancer Medicine

Published: Jan 09, 2017

WOODRIDGE, Ill., Jan. 9, 2017 /PRNewswire-iReach/ -- Shamrock Structures, LLC today announced the establishment of Shamrock Oncology, a new division of the company focused on harnessing big data analytics to drive drug discovery in personalized cancer medicine.  <o:p></o:p>

Shamrock Oncology brings together the elements of structural biology, medicinal chemistry, immunology and cell biology with the power of big data analytics to discover new personalized cancer therapies.

"New approaches to finding novel treatments against cancer are very much needed," said Michael T. Flavin, CEO of Shamrock Structures.  "The efficiency of genomic sequencing coupled with the power of computational and analytical techniques applied to large databases open new doors to understanding the molecular basis of cancer and how novel therapies can be discovered and customized for the treatment of patients." added Dr. Flavin.  "Shamrock Oncology is uniquely poised to take advantage of these trends to discover next-generation cancer therapies."

Media Contact:Nancy Tyrrell, Shamrock Structures, LLC, (630)739-3215, ntyrrell@shamrockstructures.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com 

SOURCE Shamrock Structures, LLC

Back to news